Patents by Inventor Ranadheer Ravula

Ranadheer Ravula has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10149876
    Abstract: The invention provides extracts and compositions derived from Tripterygium wilfordii for overcoming drug resistance in cancer therapy. This invention relates to organic solvent extracts of T. wilfordii and their use in cancer treatment, particularly in the treatment of cancers which have exhibited resistance to treatment by chemotherapeutic drugs. Methods of treating a cancer are disclosed. The method administers to a patient in need thereof a combination of (a) an organic solvent extract of T. wilfordii and (b) a chemotherapeutic drug. The organic solvent extract of T. wilfordii (a) and chemotherapeutic drug (b) are administered in a combined amount effective to treat the cancer. The cancer being treated is at least in part resistant to treatment by the chemotherapeutic drug (b) alone. Also disclosed are chemotherapeutic compositions comprising a combination of (a) an organic solvent extract of T.
    Type: Grant
    Filed: August 19, 2013
    Date of Patent: December 11, 2018
    Assignee: WESTERN UNIVERSITY OF HEALTH SCIENCES
    Inventors: Moses Sing Sum Chow, Ying Huang, Jinghua Jeffrey Wang, Ranadheer Ravula, Zhi Jun Wang
  • Publication number: 20160199345
    Abstract: The invention provides compositions comprising wilforlide A for overcoming drug resistance in cancer therapy, particularly in the treatment of cancers which have exhibited resistance to treatment by chemotherapeutic drugs. Methods and compositions for treating a cancer are disclosed. The method administers to a patient in need thereof a combination of wilforlide A and a chemotherapeutic drug. Wilforlide A and chemotherapeutic drug are administered in a combined amount effective to treat the can cer. The cancer being treated is at least in part resistant to treatment by the chemotherapeutic drug alone.
    Type: Application
    Filed: September 12, 2014
    Publication date: July 14, 2016
    Inventors: Moses Sing Sum CHOW, Ying HUANG, Jinghua Jeffrey WANG, Ranadheer RAVULA, Zhi Jun WANG
  • Publication number: 20150238553
    Abstract: The invention provides extracts and compositions derived from Tripterygium wilfordii for overcoming drug resist-ance in cancer therapy. This invention relates to organic solvent extracts of T. wilfordii and their use in cancer treatment, particularly in the treatment of cancers which have exhibited resistance to treatment by chemotherapeutic drugs. Methods of treating a cancer are disclosed. The method administers to a patient in need thereof a combination of (a) an organic solvent extract of T. wilfordii and (b) a chemotherapeutic drug. The organic solvent extract of T. wilfordii (a) and chemotherapeutic drug (b) are administered in a com-bined amount effective to treat the cancer. The cancer being treated is at least in part resistant to treatment by the chemotherapeutic drug (b) alone. Also disclosed are chemotherapeutic compositions comprising a combination of (a) an organic solvent extract of T.
    Type: Application
    Filed: August 19, 2013
    Publication date: August 27, 2015
    Inventors: Moses Sing Sum Chow, Ying Huang, Jinghua Jeffrey Wang, Ranadheer Ravula, Zhi Jun Wang